Results 51 to 60 of about 674 (144)
Efficacy of Once-Monthly Doses of Oral Afoxolaner and Afoxolaner/Milbemycin Oxime in a Well-Controlled Study for the Treatment of Canine Generalized Demodicosis [PDF]
Open Journal of Veterinary Medicine, 2018 The efficacy of oral treatment with chewable tablets containing afoxolaner 2.27% w/w (NexGard®, Merial, now part of Boehringer-Ingelheim) or 1.875% w/w of afoxolaner and 0.375% w/w milbemycin oxime (NexGard Spectra®, Merial, now part of Boehringer-Ingelheim) was each assessed in eight dogs diagnosed with generalized demodicosis in this parallel group ...
Steffen Rehbein +4 more
openaire +4 more sources
Assessment of afoxolaner efficacy against Otodectes cynotis infestations of dogs [PDF]
Parasites & Vectors, 2016 The efficacy of a single 2.5 mg/kg dose of afoxolaner (NexGard®, Merial) against induced Otodectes cynotis infestations was assessed in eight afoxolaner-treated dogs, compared to eight untreated dogs.After O. cynotis infestations were established and confirmed by otoscopic assessments in 16 dogs, all of the dogs were included in the study and allocated
Carithers, Doug +4 more
openaire +2 more sources
Parasites & Vectors, 2022 Background Trichodectes canis is a small chewing louse found globally that primarily infests dogs. Limited information is available on the efficacy of isoxazolines against infestation with the chewing louse.
Andrei Daniel Mihalca +4 more
doaj +1 more source
Pest Management Science, 2022 AbstractBACKGROUNDAfoxolaner is a novel representative of the isoxazolines, a class of ectoparasiticides which has been commercialized for the control of tick and flea infestations in dogs. In this study, the biological efficacy of afoxolaner against the two‐spotted spider mite Tetranychus urticae was evaluated.
Mermans, Catherine +3 more
openaire +3 more sources
The 2023 World Small Animal Veterinary Association (WSAVA)
, 2023 Journal of Small Animal Practice, Volume 64, Issue 12, Page 731-748, December 2023.
P. V. Steagall +9 more
wiley +1 more source
Chemoinformatic Approaches in the Study of Fluralaner and Afoxolaner-mediated Inhibition of l-glutamate-gated Chloride Channels [PDF]
, 2019 This work showcased the chemoinformatic study of isoxazoline ectoparasiticides: Fluralaner (FLU) and Afoxolaner (AFO) interactions with l-glutamate-gated chloride channels (3RHW).
Thomaz, Douglas Vieira +3 more
core +1 more source
Efficacy of afoxolaner plus milbemycin oxime and afoxolaner alone as treatment for sarcoptic mange in naturally infested dogs [PDF]
, 2020 Artículo de investigaciónSarcoptic mange is a pruritic, contagious, ectoparasitic skin disease that affects mammals, including the domestic dog. The objective of this study was to evaluate and compare the efficacy of afoxolaner plus milbemycin oxime ...
BAUTISTA GOMEZ, LINDA GUILIANA; 210369 +3 more
core
An assessment of canine ectoparasiticide administration compliance in the USA
Parasites & Vectors, 2022 Background This study evaluated the timing of dog owner ectoparasiticide purchases to estimate administration compliance and assess the consequent impact of dose purchase gaps on the proportion of time that dogs were protected over a 12-month period ...
Robert Lavan +5 more
doaj +1 more source
Veterinary Dermatology, EarlyView.Background: Canine atopic dermatitis (cAD) is a chronic inflammatory skin disease and has been associated with gut dysbiosis. Hypothesis/Objectives: To evaluate the efficacy of heat‐killed Lactobacillus plantarum L‐137 (HK L‐137), a postbiotic supplementation in managing cAD.
Chatkamol Kiewsiri +3 more
wiley +1 more source
Parasites & Vectors, 2018 Background A multi-centre field trial was conducted to evaluate the efficacy of afoxolaner based chewables (NexGard® or NexGard Spectra®) for the treatment of generalised demodicosis caused by Demodex canis in dogs under field conditions in France, Italy
Wilfried Lebon +16 more
doaj +1 more source